HR 5039
Life-Sustaining Prescription Drug Price Relief Act of 2019
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Life-Sustaining Prescription Drug Price Relief Act of 2019 aims to lower the cost of expensive prescription drugs by requiring the Department of Health and Human Services (HHS) to review drugs for excessive pricing and negotiate prices with manufacturers, particularly for drugs covered under Medicare. The bill establishes a public database of these price determinations and mandates that drug companies report detailed financial information about their research, advertising, and sales. It also allows Medicare to directly negotiate prices for these life-sustaining drugs, potentially capping them at 110% of prices in other developed countries, and includes penalties for manufacturers that fail to comply with reporting requirements.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Daniel Lipinski
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.